Literature DB >> 24361685

WHO 'Treatment as Prevention' guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced.

Alison E Brown1, Anthony Nardone, Valerie C Delpech.   

Abstract

The WHO guidelines recommend antiretroviral therapy (ART) begins when CD4 cell counts reach less than 500 cells to reduce HIV transmission. In the UK, 96 000 people were living with HIV (PLWHIV) in 2011, ART coverage was 84% among the diagnosed population and 42% of PLWHIV had detectable viraemia. Using published methods, we estimate starting ART at below 500 CD4 cells could have reduced the proportion of PLWHIV with detectable viraemia from 42% to 38%, whereas halving the undiagnosed population could have led to a decrease to 28%. In the UK, it is unlikely early treatment will reduce HIV transmission unless the undiagnosed population is substantially reduced.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24361685     DOI: 10.1097/QAD.0000000000000137

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

Review 1.  Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies.

Authors:  David N Burns; Cynthia Grossman; Jim Turpin; Vanessa Elharrar; Fulvia Veronese
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

2.  How Many HIV infections may be averted by targeting primary infection in men who have sex with men? Quantification of changes in transmission-risk behavior, using an individual-based model.

Authors:  Peter J White; Julie Fox; Jonathan Weber; Sarah Fidler; Helen Ward
Journal:  J Infect Dis       Date:  2014-12-01       Impact factor: 5.226

3.  From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany.

Authors:  Daniel Schmidt; Christian Kollan; Matthias Stoll; Hans-Jürgen Stellbrink; Andreas Plettenberg; Gerd Fätkenheuer; Frank Bergmann; Johannes R Bogner; Jan van Lunzen; Jürgen Rockstroh; Stefan Esser; Björn-Erik Ole Jensen; Heinz-August Horst; Carlos Fritzsche; Andrea Kühne; Matthias an der Heiden; Osamah Hamouda; Barbara Bartmeyer
Journal:  BMC Public Health       Date:  2015-03-17       Impact factor: 3.295

4.  Long term effect of primary health care training on HIV testing: A quasi-experimental evaluation of the Sexual Health in Practice (SHIP) intervention.

Authors:  Kamla Pillay; Melissa Gardner; Allon Gould; Susan Otiti; Judith Mullineux; Till Bärnighausen; Philippa Margaret Matthews
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

Review 5.  Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: a rapid-realist review.

Authors:  Seth Francis-Graham; Nnenna Adaniya Ekeke; Corey Andrew Nelson; Tin Yan Lee; Sulaima El Haj; Tim Rhodes; Cecilia Vindrola; Tim Colbourn; William Rosenberg
Journal:  BMC Health Serv Res       Date:  2019-03-08       Impact factor: 2.655

6.  Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UK.

Authors:  Lauren Bull; Pavle Dimitrijevic; Sophie Beverley; Alex Scarborough; Sundhiya Mandalia; Olamide Dosekun; Tristan Barber; Iain Reeves; Sheena McCormack; Michael Rayment
Journal:  Int J STD AIDS       Date:  2017-09-20       Impact factor: 1.359

7.  Key factors in the acceptability of treatment as prevention (TasP) in Scotland: a qualitative study with communities affected by HIV.

Authors:  I Young; P Flowers; L M McDaid
Journal:  Sex Transm Infect       Date:  2014-12-07       Impact factor: 3.519

8.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321

9.  Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants.

Authors:  D Van Beckhoven; E Florence; J Ruelle; J Deblonde; C Verhofstede; S Callens; E Vancutsem; P Lacor; R Demeester; J-C Goffard; A Sasse
Journal:  BMC Infect Dis       Date:  2015-11-03       Impact factor: 3.090

10.  Towards standardized definitions for monitoring the continuum of HIV care in Europe.

Authors:  Annabelle J Gourlay; Anastasia M Pharris; Teymur Noori; Virginie Supervie; Magdalena Rosinska; Ard van Sighem; Giota Touloumi; Kholoud Porter
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.